港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

劲方医药-B

31.360

-0.640-2.00%

成交量：35.26万

成交额：1,112.52万

市值：116.03亿

市盈率：-15.87

高：32.280

开：32.020

低：30.800

收：32.000

52周最高：50.200

52周最低：24.320

股本：3.70亿

香港流通股本：3.38亿

量比：0.30

换手率：0.10%

股息：- -

股息率：- -

每股收益(LYR):-1.976

净资产收益率：--

总资产收益率：-30.27%

市净率：-4.02

市盈率(LYR):-15.87

市销率: 54.86

数据加载中...

总览公司新闻资讯公告

劲方医药-B拟9月30日通过董事书面决议以审批中期报告

格隆汇资讯

驶入新航道下一站！劲方医药（2595.HK）在香港联交所主板挂牌上市

写意电报 | 劲方医药港股IPO，开盘大涨逾128%

中信证券独家保荐生物科技领先公司劲方医药成功登陆港交所

中信证券发布

简讯：超额2,660倍劲方医药首挂午收升逾倍

农银国际助力劲方医药成功在香港联交所上市

上市首日暴涨115%！劲方医药核心产品获批上市

生物药大时代

异动解读 | 抗癌新药研发公司劲方医药上市首日大涨115%，创新药物管线获市场认可

新股首日｜劲方医药涨超115%，一手赚超4700港元

老虎资讯综合

劲方医药-B港股上市首日预计以每股44港元开盘，发行价为20.39港元

港股IPO动态：今日劲方医药上市

劲方医药-B(02595)：香港公开发售获2662.79倍认购全球发售净筹约16.7亿港元

新股暗盘 | 劲方医药-B(02595)暗盘盘初涨超115% 每手赚4722港元

老虎暗盘丨劲方医药盘初暴涨115%，每手赚超4700港元

老虎资讯综合

刷新港股18A纪录！国产RAS创新药龙头劲方医药即将敲钟

动脉新医药

一图解码：港股IPO一周回顾 4家公司递表大行科工上市首日高开

劲方医药(2595.HK)孖展超购逾1389倍

新股孖展统计 | 9月15日

IPO观察丨劲方医药将在港交所上市，两年多亏损超12亿元，明星机构云集

港股IPO动态：今日劲方医药、健康160申购

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02595/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"劲方医药-B","latestPrice":31.36,"timestamp":1763366893755,"preClose":32,"halted":0,"volume":352600,"delay":0,"floatShares":338000000,"shares":370000000,"eps":-1.976,"marketStatus":"未开盘","change":-0.64,"latestTime":"11-17 16:08:13","open":32.02,"high":32.28,"low":30.8,"amount":11125210,"amplitude":0.04625,"askPrice":31.48,"askSize":1800,"bidPrice":31.36,"bidSize":2200,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":32,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":0.3016404414856207,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":338000000,"roa":"-30.27%","roe":"--","lyrEps":-1.976,"volumeRatio":0.3016404414856207,"shares":370000000,"dividePrice":0,"high":32.28,"amplitude":0.04625,"preClose":32,"low":30.8,"week52Low":24.32,"pbRate":"-4.02","psRate":"54.86","week52High":50.2,"institutionHeld":0,"latestPrice":31.36,"committee":0.1,"eps":-1.976,"divideRate":0,"volume":352600,"delay":0,"ttmEps":-2.744,"open":32.02,"prevYearClose":20.39,"prevWeekClose":32,"prevMonthClose":27.32,"prevQuarterClose":40,"fiveDayClose":29.24,"twentyDayClose":31.8,"sixtyDayClose":20.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2025-11-14","current":-11.428571,"percent":0.405405,"low":-19.62221,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"high":-9.058573,"avg":-12.958612,"sd":3.82741,"marketCap":11851732160},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-14","current":-11.674836,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"marketCap":11851732160}],"updateTime":1763397858541},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568026250","title":"劲方医药-B拟9月30日通过董事书面决议以审批中期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2568026250","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568026250?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 19:39","pubTimestamp":1758281989,"startTime":"0","endTime":"0","summary":"格隆汇9月19日丨劲方医药-B(02595.HK)公告，将于2025年9月30日(星期二)(香港时间)以书面决议方式审议及批准公司截至2025年6月30日止六个月的中期报告及其刊发事宜，并审议中期股息派付事宜(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919193957979d1f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919193957979d1f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2568257101","title":"驶入新航道下一站！劲方医药（2595.HK）在香港联交所主板挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2568257101","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568257101?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 19:01","pubTimestamp":1758279692,"startTime":"0","endTime":"0","summary":"来源：市场资讯 9月19日，张江药谷企业劲方医药在香港联合交易所主板正式挂牌上市。超额配售权行使前发行规模为2.33亿美元，超额配售权行使后将达2.68亿美元，募资总额创2022年以来港股 18A 板块之最。劲方医药为IPO阶段首个拥有上市产品及授权收入的18A板块新药企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919190827979d138f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919190827979d138f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","BK1574","02595"],"gpt_icon":1},{"id":"2568372002","title":"写意电报 | 劲方医药港股IPO，开盘大涨逾128%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568372002","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568372002?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 14:44","pubTimestamp":1758264268,"startTime":"0","endTime":"0","summary":"来源：市场资讯（来源：写意宣发）写意电报 | 劲方医药港股IPO，开盘大涨逾128%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091914502695381897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091914502695381897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595"],"gpt_icon":0},{"id":"2568316237","title":"中信证券独家保荐生物科技领先公司劲方医药成功登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2568316237","media":"中信证券发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568316237?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 14:28","pubTimestamp":1758263305,"startTime":"0","endTime":"0","summary":"中信证券担任独家保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。中信证券全球投资银行管理委员会联席主任程杰、全球投资银行管理委员会委员于杨出席上市仪式。此次上市，中信银行以独家收款行身份，与中信证券高效协同共同服务客户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919143222979ca0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919143222979ca0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02595","LU1794554557.SGD","BK1161","BK1147","BK1521","LU1720050803.USD","09939","06030","BK1516","BK1564","BK1515"],"gpt_icon":1},{"id":"2568234034","title":"简讯：超额2,660倍 劲方医药首挂午收升逾倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2568234034","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568234034?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 13:22","pubTimestamp":1758259378,"startTime":"0","endTime":"0","summary":"来源：市场资讯（来源：BBW咏竹坊）生物制药公司劲方医药科技（上海）股份有限公司（2595.HK）周五首日在香港挂牌，开市即升116%报44港元，之后股价在此上落，中午收报44.06港元。公司发售8,924万股，每股售价20.39港元，公开发售录得超额认购近2,662倍，国际配售超额38倍，集资净额16.7亿港元。由于在研发活动上作出大量投资，加上股份权益赎回负债公允价值变动，劲方医药去年及今年分别录得亏损5.1亿人民币及6.78亿元，今年首四个月仍亏损6,660万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509191327259537f6cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509191327259537f6cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02595","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2568231278","title":"农银国际助力劲方医药成功在香港联交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2568231278","media":"农银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568231278?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 12:50","pubTimestamp":1758257409,"startTime":"0","endTime":"0","summary":"2025年9月19日，农银国际作为整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人协助劲方医药科技（上海）股份有限公司在香港交易所主板成功上市。劲方医药此次发行价格为每股20.39港元，募集资金约2.33亿美金（绿鞋前）。农银国际凭借自身对生物医药行业及国际资本市场的深刻洞察，把握港股生物医药板块回暖窗口，引入了多家优质投资人，为公司成功上市保驾护航。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509191259319537eb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509191259319537eb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1515","BK1574","BK1161"],"gpt_icon":1},{"id":"2568235032","title":"上市首日暴涨115%！劲方医药核心产品获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2568235032","media":"生物药大时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568235032?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 10:47","pubTimestamp":1758250043,"startTime":"0","endTime":"0","summary":"劲方医药是一家立足于中国、面向全球的创新药研发企业，专注于肿瘤、自体免疫及炎症疾病领域。截至最后实际可行日期，公司已建立起一条产品管线，包括八款候选药品，其中五款处于临床开发阶段，包括两款核心产品－GFH925和GFH375。劲方医药的核心产品GFH925在中国以达伯特的品牌名称上市，是一款自主发现的小分子选择性KRAS G12C蛋白抑制剂。劲方医药的收入主要来自三名与多项履约责任有关的客户，包括知识产权的授权；研发服务及2024年提供药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919111402979c5570&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919111402979c5570&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1161","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"1154544861","title":"异动解读 | 抗癌新药研发公司劲方医药上市首日大涨115%，创新药物管线获市场认可","url":"https://stock-news.laohu8.com/highlight/detail?id=1154544861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154544861?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 09:32","pubTimestamp":1758245558,"startTime":"0","endTime":"0","summary":"9月19日，专注于肿瘤和自体免疫疾病新药研发的劲方医药-B在港交所主板挂牌上市。开盘即以44港元高开，较发行价20.39港元大涨115.60%，市值达到约391亿港元，成为今年以来港股生物科技板块最亮眼的新股之一。公司核心产品GFH925已于今年8月在中国获批上市，是国内首款、全球第三款获批的KRAS G12C抑制剂，用于治疗非小细胞肺癌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7639f6519ce223e17f2bea5287747aa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02595"],"gpt_icon":1},{"id":"1155095881","title":"新股首日｜劲方医药涨超115%，一手赚超4700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155095881","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155095881?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 09:25","pubTimestamp":1758245131,"startTime":"0","endTime":"0","summary":"劲方医药涨超115%，一手赚超4700港元，劲方医药是一家专注于开发肿瘤、自体免疫和炎症性疾病的新治疗方案的制药企业。2024年7月，劲方医药也启动了GFH375的临床试验。招股书显示，劲方医药2023年、2024年营收分别为7373万、1.05亿元；毛利分别为7305万、8461万；期内亏损分别为5.08亿元、6.78亿元。截至2025年4月30日，劲方医药持有的现金及现金等价物为3.91亿元。","market":"us","thumbnail":"https://static.tigerbbs.com/cd659cf17d502b970012ba9d2f3e6693","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cd659cf17d502b970012ba9d2f3e6693"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7639f6519ce223e17f2bea5287747aa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1102059219","title":"劲方医药-B港股上市首日预计以每股44港元开盘，发行价为20.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102059219","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102059219?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 09:21","pubTimestamp":1758244879,"startTime":"0","endTime":"0","summary":"劲方医药-B港股上市首日预计以每股44港元开盘，发行价为20.39港元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7639f6519ce223e17f2bea5287747aa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2568289843","title":"港股IPO动态：今日劲方医药上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2568289843","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568289843?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 06:09","pubTimestamp":1758233391,"startTime":"0","endTime":"0","summary":"格隆汇9月19日｜今日劲方医药-B(2595.HK)上市，奇瑞汽车(9973.HK)申购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919061013a4ce6047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919061013a4ce6047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","HSTECH","HSCEI","02595","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2568065044","title":"劲方医药-B(02595)：香港公开发售获2662.79倍认购 全球发售净筹约16.7亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568065044","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568065044?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 22:49","pubTimestamp":1758206966,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)公布配发结果，公司全球发售8924万股股份，香港公开发售占8.7%，国际发售占91.3%。每股发售价20.39港元，全球发售净筹约16.7亿港元。每手200股，预期H股将于2025年9月19日(星期五)上午九时正开始在联交所买卖。其中，香港公开发售获2662.79倍认购，国际发售获39.05倍认购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e982c265fdd89761c7677dd2228fb52f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","159938","09939","BK1161","02595"],"gpt_icon":0},{"id":"2568591422","title":"新股暗盘 | 劲方医药-B(02595)暗盘盘初涨超115% 每手赚4722港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568591422","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568591422?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 16:16","pubTimestamp":1758183402,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，劲方医药-B(02595)将于9月19日(周五)在香港挂牌。截至发稿，暗盘交易显示报价44港元，较招股价20.39港元上涨115.79%，每手200股，不计手续费，每手赚4722港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e982c265fdd89761c7677dd2228fb52f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1515","BK1161","BK1574","02595","159938"],"gpt_icon":0},{"id":"1102955154","title":"老虎暗盘丨劲方医药盘初暴涨115%，每手赚超4700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102955154","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102955154?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 16:15","pubTimestamp":1758183333,"startTime":"0","endTime":"0","summary":"劲方医药是一家创新药物开发企业。","market":"hk","thumbnail":"https://static.tigerbbs.com/cd659cf17d502b970012ba9d2f3e6693","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cd659cf17d502b970012ba9d2f3e6693"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e982c265fdd89761c7677dd2228fb52f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2568628446","title":"刷新港股18A纪录！国产RAS创新药龙头劲方医药即将敲钟","url":"https://stock-news.laohu8.com/highlight/detail?id=2568628446","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568628446?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 08:01","pubTimestamp":1758153682,"startTime":"0","endTime":"0","summary":"基石投资者认购总额已达1亿美元，也创2022年以来港股 18A 生物科技公司新高。氟泽雷塞于2024年8月上市，为中国首个、全球第三个获批上市的KRAS G12C抑制剂。NSCLC、CRC、PDAC发病人数持续攀升。作为全球首个KRAS+EGFR一线肺癌联合疗法，其总体疗效优秀，且具有显著的脑转移肿瘤缓解、优于氟泽雷塞二线单药治疗的安全性。此外，GFH375有望与劲方的泛RAS抑制剂、EGFR-Pan RAS偶联药物，以及恶病质双抗GFS202A在未来形成狙击胰腺癌的疗法矩阵。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509180831179535206d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509180831179535206d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","HSTECH","BK1515","BK1161","HSCEI","09939","02595","BK1574"],"gpt_icon":1},{"id":"2567112088","title":"一图解码：港股IPO一周回顾 4家公司递表 大行科工上市首日高开","url":"https://stock-news.laohu8.com/highlight/detail?id=2567112088","media":"IPO解码","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567112088?lang=zh_cn&edition=fundamental","pubTime":"2025-09-16 10:21","pubTimestamp":1757989307,"startTime":"0","endTime":"0","summary":"大行科工于2025年9月9日正式登陆港交所。上市首日，大行科工开盘报67.5港元，较发行价涨36.36%；盘中股价涨幅收窄，截至当天收盘报56.9港元，涨14.95%。此外，上周仍有A股公司宣布启动赴港IPO筹备工作，其中包括贝达药业、美锦能源和千里科技。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161052429794fc72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161052429794fc72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","02259","02656","06090","02595","02543","HSTECH","02525"],"gpt_icon":1},{"id":"2567411682","title":"劲方医药(2595.HK)孖展超购逾1389倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2567411682","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567411682?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 19:14","pubTimestamp":1757934841,"startTime":"0","endTime":"0","summary":"格隆汇9月15日｜生物制药公司劲方医药-B(2595.HK)明日(16日)截飞，截至目前，券商累计为其借出2196.43亿港元孖展，以公开发售集资额1.58亿港元计，相当于超购逾1389倍。劲方医药专注于肿瘤以及自体免疫和炎症性疾病领域的新治疗方案开发，预期周五(19日)挂牌，集资最多15.82亿港元，中信证券为保荐人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915191408a4c753a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915191408a4c753a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02595","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2567388115","title":"新股孖展统计 | 9月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2567388115","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567388115?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 18:53","pubTimestamp":1757933620,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，劲方医药-B(02595)、不同集团(06090)正在招股中。截止9月15日，富途、辉立、华盛等券商合计为劲方医药-B借出2196.4325亿港元，超购逾1389倍；合计为不同集团借出 9.3389亿港元，超购逾10.9倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06090","BK1574","09939","BK1161","02595","BK1515","BK1229","BK1258"],"gpt_icon":0},{"id":"2567194448","title":"IPO观察丨劲方医药将在港交所上市，两年多亏损超12亿元，明星机构云集","url":"https://stock-news.laohu8.com/highlight/detail?id=2567194448","media":"红星新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567194448?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 16:30","pubTimestamp":1757925000,"startTime":"0","endTime":"0","summary":"劲方医药预期，GFH925将符合2026年国家医保药品目录的谈判资格。目前，GFH925的专利期限尚余超过15年。两年多亏损超12亿知名机构投资者云集目前，劲方医药的收入来自公司与信达生物就GFH925的合作、与Verastem就GFH375的合作及与SELLAS就GFH009的合作。两年多时间合计亏损超过12亿元。劲方医药有两名联合创始人。自2017年成立以来，劲方医药累计完成7轮融资，融资总额达14.21亿元。劲方医药此次IPO，募资净额约14.44亿港元，其中约71.0%将用作核心产品GFH925及GFH375的进一步开发资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915163053979316ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915163053979316ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2566912619","title":"港股IPO动态：今日劲方医药、健康160申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2566912619","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566912619?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 06:11","pubTimestamp":1757628667,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"68fe90f0aac15dc240da840f80cf3c51","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09939","BK1515","BK1574","159938","BK1161","02595","02656"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":73,"code":"91000000","status":"200"}]}}